Pacer Advisors’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.66M Buy
10,925
+7,408
+211% +$1.23M ﹤0.01% 1087
2026
Q1
$738K Sell
3,517
-2,039
-37% -$512K ﹤0.01% 1328
2025
Q4
$1.58M Sell
5,556
-399
-7% -$125K ﹤0.01% 1222
2025
Q3
$1.84M Sell
5,955
-195
-3% -$61.1K ﹤0.01% 1132
2025
Q2
$1.93M Buy
6,150
+2,546
+71% +$735K ﹤0.01% 1034
2025
Q1
$946K Sell
3,604
-2,005
-36% -$543K ﹤0.01% 1229
2024
Q4
$1.46M Sell
5,609
-921
-14% -$232K ﹤0.01% 1170
2024
Q3
$1.52M Buy
6,530
+24
+0.4% +$4.93K ﹤0.01% 1121
2024
Q2
$1.31M Buy
6,506
+1,734
+36% +$312K ﹤0.01% 1156
2024
Q1
$818K Sell
4,772
-932
-16% -$174K ﹤0.01% 1340
2023
Q4
$1.24M Sell
5,704
-2,343
-29% -$402K ﹤0.01% 1028
2023
Q3
$1.28M Buy
8,047
+955
+13% +$214K ﹤0.01% 734
2023
Q2
$2.04M Buy
7,092
+2,848
+67% +$865K 0.01% 721
2023
Q1
$1.35M Buy
+4,244
New +$1.26M 0.01% 813

Other funds holding PODD

Pacer Advisors's PODD Position: Q2 2026 in Review

Pacer Advisors increased its Insulet (PODD) stake by 211% in Q2 2026, buying an estimated $1.23M and bringing the position to 10,925 shares worth $1.66M. The position accounts for ﹤0.01% of the portfolio, ranked #1087.

Pacer Advisors first reported a position in PODD in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.04M in Q2 2023. 727 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Pacer Advisors held 10,925 shares of Insulet worth $1.66M as of Q2 2026.
  • Pacer Advisors bought 7,408 Insulet shares in Q2 2026, an estimated $1.23M.
  • Insulet made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #1087 holding.
  • Pacer Advisors first reported a position in Insulet in Q1 2023 and has held it in 14 quarters since.
  • Pacer Advisors's Insulet position peaked at $2.04M in Q2 2023.
  • 727 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.